CSIMarket
 


Cerus Corporation  (CERS)
Other Ticker:  
 

Cerus's Quick Ratio

CERS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




CERS Quick Ratio (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Change 46.82 % 20.46 % 21.72 % 30.98 % 40.11 %
Y / Y Cash & cash equivalent Change -13.45 % -12.86 % -17.59 % -3.17 % -11.22 %
Quick Ratio MRQ 1.09 1.35 1.63 1.65 1.85
Overall Ranking # # # # #
Seq. Current Liabilities Change 19.85 % 18.93 % -15.14 % 21.38 % -1.67 %
Seq. Cash & cash equivalent Change -3.01 % -1.39 % -16.08 % 7.83 % -2.34 %



Quick Ratio third quarter 2022 Comment
Due to increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 1.09 above Cerus Corporation average.

Within Medical Equipment & Supplies industry Cerus Corporation booked the highest Quick Ratio than Cerus in the third quarter 2022. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are CERS Segments?
See Quick Ratio CERS on the trailing twelve month basis
Quick Ratio third quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall Market #


Quick Ratio Statistics
High Average Low
0 0 0
 




Financial Statements
Cerus's Current Liabilities $ 95 Millions Visit CERS's Balance sheet
Cerus's Cash & cash equivalent $ 104 Millions Visit CERS's Balance sheet
Source of CERS's Sales Visit CERS's Sales by Geography


Cumulative Cerus's Quick Ratio

CERS's Quick Ratio for the trailling 12 Months

CERS Quick Ratio

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities TTM Growth 46.82 % 20.46 % 21.72 % 30.98 % 40.11 %
Y / Y Cash & cash equivalent TTM Growth -13.45 % -12.86 % -17.59 % -3.17 % -11.22 %
Quick Ratio TTM 1.4 1.61 1.74 1.91 2.07
Total Ranking TTM # 1348 # 558 # 1676 # 1713 # 920
Seq. Current Liabilities TTM Growth 19.85 % 18.93 % -15.14 % 21.38 % -1.67 %
Seq. Cash & cash equivalent TTM Growth -3.01 % -1.39 % -16.08 % 7.83 % -2.34 %


TTM Quick Ratio Comment
On the trailing twelve months basis Due to increase in Current Liabilities in the III. Quarter to $95.02 millions, average cumulative Quick Ratio decreased to 1.4 below the Cerus Corporation average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 100 other companies have achieved higher Quick Ratio than Cerus. While overall ranking remained unchanged compare to previous quarter at no. 1348.

Explain Quick Ratio?
What are CERS Segments?
See Quick Ratio CERS on the trailing twelve month basis

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 101
Healthcare Sector # 688
Within the Market # 1348


TTM Quick Ratio Statistics
High Average Low
5.19 2.82 1.4
(Dec. 30, 2015)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Medical Equipment & Supplies Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Nephros Inc   2.98 $ 3.940  Millions$ 1.322  Millions
Plus Therapeutics Inc   2.77 $ 20.266  Millions$ 7.313  Millions
Koru Medical Systems Inc   2.67 $ 16.441  Millions$ 6.168  Millions
Atrion Corporation  2.65 $ 47.421  Millions$ 17.879  Millions
Cutera Inc   2.63 $ 250.826  Millions$ 95.546  Millions
Motus Gi Holdings Inc   2.55 $ 13.294  Millions$ 5.219  Millions
Avinger Inc  2.45 $ 17.342  Millions$ 7.072  Millions
Intelligent Bio Solutions Inc   2.44 $ 5.743  Millions$ 2.357  Millions
Axogen inc   2.41 $ 53.110  Millions$ 22.017  Millions
Better Therapeutics Inc   2.40 $ 22.305  Millions$ 9.312  Millions
Alphatec Holdings Inc   2.26 $ 106.112  Millions$ 46.924  Millions
Sharecare Inc   2.25 $ 202.564  Millions$ 89.944  Millions
Cytosorbents Corporation  2.23 $ 22.552  Millions$ 10.119  Millions
Atricure Inc   2.13 $ 122.644  Millions$ 57.598  Millions
Universal Biosensors Inc   2.06 $ 26.933  Millions$ 13.044  Millions
First America Resources Corporation  2.06 $ 0.015  Millions$ 0.008  Millions
Stereotaxis Inc   1.99 $ 30.938  Millions$ 15.554  Millions
Lensar Inc   1.97 $ 19.293  Millions$ 9.788  Millions
Petvivo Holdings Inc   1.97 $ 2.350  Millions$ 1.194  Millions
T2 Biosystems Inc   1.89 $ 20.366  Millions$ 10.780  Millions
Globus Medical Inc   1.87 $ 271.063  Millions$ 145.255  Millions
Warby Parker Inc   1.78 $ 197.885  Millions$ 111.484  Millions
Livanova Plc  1.76 $ 506.279  Millions$ 288.016  Millions
Pear Therapeutics Inc   1.74 $ 83.619  Millions$ 48.155  Millions
Abiomed Inc   1.69 $ 182.335  Millions$ 108.098  Millions
Icad Inc   1.68 $ 24.590  Millions$ 14.601  Millions
Integra Lifesciences Holdings Corp  1.68 $ 511.937  Millions$ 304.452  Millions
Biolife Solutions Inc  1.67 $ 61.619  Millions$ 36.948  Millions
Sintx Technologies Inc   1.66 $ 4.779  Millions$ 2.872  Millions
Mimedx Group Inc   1.60 $ 73.217  Millions$ 45.858  Millions

Date modified: 2022-11-06T03:35:36+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ADNT's Profile

Stock Price

ADNT's Financials

Business Description

Fundamentals

Charts & Quotes

ADNT's News

Suppliers

ADNT's Competitors

Customers & Markets

Economic Indicators

ADNT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071